Selected research
Market Structure
Global Preterm Birth Prevention and Management Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Preterm Birth Prevention and Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Preterm Birth Prevention and Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Preterm Birth Prevention and Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Preterm Birth Prevention and Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Preterm Birth Prevention and Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Preterm Birth Prevention and Management include Teva, Sanofi, Novartis, Pfizer, Bayer, AbbVie, Viatris, Merck & Co and Ferring Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Preterm Birth Prevention and Management market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Preterm Birth Prevention and Management and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Preterm Birth Prevention and Management revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Preterm Birth Prevention and Management market size, projected growth trends, production technologies, key applications, and end-use industries.
Preterm Birth Prevention and Management Segment by Company
Teva
Sanofi
Novartis
Pfizer
Bayer
AbbVie
Viatris
Merck & Co
Ferring Pharmaceutical
Aurobindo Pharma
AMAG Pharmaceuticals
Allergan
Preterm Birth Prevention and Management Segment by Type
Antihypertensive Therapy
Magnesium Sulfate Therapy
Corticosteroid Therapy
Tocolytics Therapy
Progesterone Therapy
Other
Preterm Birth Prevention and Management Segment by Application
Hospital
Drugs Stores
Other
Preterm Birth Prevention and Management Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preterm Birth Prevention and Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Preterm Birth Prevention and Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preterm Birth Prevention and Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Preterm Birth Prevention and Management in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Preterm Birth Prevention and Management industry.
Chapter 3: Detailed analysis of Preterm Birth Prevention and Management companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Preterm Birth Prevention and Managementrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Antihypertensive Therapy
- Magnesium Sulfate Therapy
- Corticosteroid Therapy
- Tocolytics Therapy
- Progesterone Therapy
- Other
Applications
- Hospital
- Drugs Stores
- Other
Companies covered
- Teva
- Sanofi
- Novartis
- Pfizer
- Bayer
- AbbVie
- Viatris
- Merck & Co
- Ferring Pharmaceutical
- Aurobindo Pharma
- AMAG Pharmaceuticals
- Allergan
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Preterm Birth Prevention and Management Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Antihypertensive Therapy
- 1.2.3 Magnesium Sulfate Therapy
- 1.2.4 Corticosteroid Therapy
- 1.2.5 Tocolytics Therapy
- 1.2.6 Progesterone Therapy
- 1.2.7 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global Preterm Birth Prevention and Management Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Drugs Stores
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Preterm Birth Prevention and Management Growth Trends by Region
- 1.5.1 Global Preterm Birth Prevention and Management Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Preterm Birth Prevention and Management Market Size by Region (2021-2026)
- 1.5.3 Preterm Birth Prevention and Management Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Preterm Birth Prevention and Management Market Dynamics
- 2.1 Preterm Birth Prevention and Management Industry Trends
- 2.2 Preterm Birth Prevention and Management Industry Drivers
- 2.3 Preterm Birth Prevention and Management Industry Opportunities and Challenges
- 2.4 Preterm Birth Prevention and Management Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Preterm Birth Prevention and Management Revenue by Company (2021-2026)
- 3.2 Global Preterm Birth Prevention and Management Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Preterm Birth Prevention and Management Key Company Head office and Area Served
- 3.4 Global Preterm Birth Prevention and Management Company, Product Type & Application
- 3.5 Global Preterm Birth Prevention and Management Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Preterm Birth Prevention and Management Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Preterm Birth Prevention and Management Players Market Share by Revenue in 2025
- 3.6.3 2025 Preterm Birth Prevention and Management Tier 1, Tier 2, and Tier 3
4 Preterm Birth Prevention and Management Market by Type
- 4.1 Global Preterm Birth Prevention and Management Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Preterm Birth Prevention and Management Market Size by Type (2021-2032)
- 4.3 Global Preterm Birth Prevention and Management Market Size Share by Type (2021-2032)
5 Preterm Birth Prevention and Management Market by Application
- 5.1 Global Preterm Birth Prevention and Management Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Preterm Birth Prevention and Management Market Size by Application (2021-2032)
- 5.3 Global Preterm Birth Prevention and Management Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Teva
- 6.1.1 Teva Company Information
- 6.1.2 Teva Business Overview
- 6.1.3 Teva Preterm Birth Prevention and Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Teva Preterm Birth Prevention and Management Product Portfolio
- 6.1.5 Teva Recent Developments
- 6.2 Sanofi
- 6.2.1 Sanofi Company Information
- 6.2.2 Sanofi Business Overview
- 6.2.3 Sanofi Preterm Birth Prevention and Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Sanofi Preterm Birth Prevention and Management Product Portfolio
- 6.2.5 Sanofi Recent Developments
- 6.3 Novartis
- 6.3.1 Novartis Company Information
- 6.3.2 Novartis Business Overview
- 6.3.3 Novartis Preterm Birth Prevention and Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Novartis Preterm Birth Prevention and Management Product Portfolio
- 6.3.5 Novartis Recent Developments
- 6.4 Pfizer
- 6.4.1 Pfizer Company Information
- 6.4.2 Pfizer Business Overview
- 6.4.3 Pfizer Preterm Birth Prevention and Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Pfizer Preterm Birth Prevention and Management Product Portfolio
- 6.4.5 Pfizer Recent Developments
- 6.5 Bayer
- 6.5.1 Bayer Company Information
- 6.5.2 Bayer Business Overview
- 6.5.3 Bayer Preterm Birth Prevention and Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Bayer Preterm Birth Prevention and Management Product Portfolio
- 6.5.5 Bayer Recent Developments
- 6.6 AbbVie
- 6.6.1 AbbVie Company Information
- 6.6.2 AbbVie Business Overview
- 6.6.3 AbbVie Preterm Birth Prevention and Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 AbbVie Preterm Birth Prevention and Management Product Portfolio
- 6.6.5 AbbVie Recent Developments
- 6.7 Viatris
- 6.7.1 Viatris Company Information
- 6.7.2 Viatris Business Overview
- 6.7.3 Viatris Preterm Birth Prevention and Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Viatris Preterm Birth Prevention and Management Product Portfolio
- 6.7.5 Viatris Recent Developments
- 6.8 Merck & Co
- 6.8.1 Merck & Co Company Information
- 6.8.2 Merck & Co Business Overview
- 6.8.3 Merck & Co Preterm Birth Prevention and Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Merck & Co Preterm Birth Prevention and Management Product Portfolio
- 6.8.5 Merck & Co Recent Developments
- 6.9 Ferring Pharmaceutical
- 6.9.1 Ferring Pharmaceutical Company Information
- 6.9.2 Ferring Pharmaceutical Business Overview
- 6.9.3 Ferring Pharmaceutical Preterm Birth Prevention and Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Ferring Pharmaceutical Preterm Birth Prevention and Management Product Portfolio
- 6.9.5 Ferring Pharmaceutical Recent Developments
- 6.10 Aurobindo Pharma
- 6.10.1 Aurobindo Pharma Company Information
- 6.10.2 Aurobindo Pharma Business Overview
- 6.10.3 Aurobindo Pharma Preterm Birth Prevention and Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Aurobindo Pharma Preterm Birth Prevention and Management Product Portfolio
- 6.10.5 Aurobindo Pharma Recent Developments
- 6.11 AMAG Pharmaceuticals
- 6.11.1 AMAG Pharmaceuticals Company Information
- 6.11.2 AMAG Pharmaceuticals Business Overview
- 6.11.3 AMAG Pharmaceuticals Preterm Birth Prevention and Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 AMAG Pharmaceuticals Preterm Birth Prevention and Management Product Portfolio
- 6.11.5 AMAG Pharmaceuticals Recent Developments
- 6.12 Allergan
- 6.12.1 Allergan Company Information
- 6.12.2 Allergan Business Overview
- 6.12.3 Allergan Preterm Birth Prevention and Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Allergan Preterm Birth Prevention and Management Product Portfolio
- 6.12.5 Allergan Recent Developments
7 North America
- 7.1 North America Preterm Birth Prevention and Management Market Size (2021-2032)
- 7.2 North America Preterm Birth Prevention and Management Market Size by Type
- 7.2.1 North America Preterm Birth Prevention and Management Market Size by Type (2021-2026)
- 7.2.2 North America Preterm Birth Prevention and Management Market Size by Type (2027-2032)
- 7.2.3 North America Preterm Birth Prevention and Management Market Share by Type (2021-2032)
- 7.3 North America Preterm Birth Prevention and Management Market Size by Application
- 7.3.1 North America Preterm Birth Prevention and Management Market Size by Application (2021-2026)
- 7.3.2 North America Preterm Birth Prevention and Management Market Size by Application (2027-2032)
- 7.3.3 North America Preterm Birth Prevention and Management Market Share by Application (2021-2032)
- 7.4 North America Preterm Birth Prevention and Management Market Size by Country
- 7.4.1 North America Preterm Birth Prevention and Management Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Preterm Birth Prevention and Management Market Size by Country (2021-2026)
- 7.4.3 North America Preterm Birth Prevention and Management Market Size by Country (2027-2032)
- 7.4.4 North America Preterm Birth Prevention and Management Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Preterm Birth Prevention and Management Market Size (2021-2032)
- 8.2 Europe Preterm Birth Prevention and Management Market Size by Type
- 8.2.1 Europe Preterm Birth Prevention and Management Market Size by Type (2021-2026)
- 8.2.2 Europe Preterm Birth Prevention and Management Market Size by Type (2027-2032)
- 8.2.3 Europe Preterm Birth Prevention and Management Market Share by Type (2021-2032)
- 8.3 Europe Preterm Birth Prevention and Management Market Size by Application
- 8.3.1 Europe Preterm Birth Prevention and Management Market Size by Application (2021-2026)
- 8.3.2 Europe Preterm Birth Prevention and Management Market Size by Application (2027-2032)
- 8.3.3 Europe Preterm Birth Prevention and Management Market Share by Application (2021-2032)
- 8.4 Europe Preterm Birth Prevention and Management Market Size by Country
- 8.4.1 Europe Preterm Birth Prevention and Management Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Preterm Birth Prevention and Management Market Size by Country (2021-2026)
- 8.4.3 Europe Preterm Birth Prevention and Management Market Size by Country (2027-2032)
- 8.4.4 Europe Preterm Birth Prevention and Management Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Preterm Birth Prevention and Management Market Size (2021-2032)
- 9.2 China Preterm Birth Prevention and Management Market Size by Type
- 9.2.1 China Preterm Birth Prevention and Management Market Size by Type (2021-2026)
- 9.2.2 China Preterm Birth Prevention and Management Market Size by Type (2027-2032)
- 9.2.3 China Preterm Birth Prevention and Management Market Share by Type (2021-2032)
- 9.3 China Preterm Birth Prevention and Management Market Size by Application
- 9.3.1 China Preterm Birth Prevention and Management Market Size by Application (2021-2026)
- 9.3.2 China Preterm Birth Prevention and Management Market Size by Application (2027-2032)
- 9.3.3 China Preterm Birth Prevention and Management Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Preterm Birth Prevention and Management Market Size (2021-2032)
- 10.2 Asia Preterm Birth Prevention and Management Market Size by Type
- 10.2.1 Asia Preterm Birth Prevention and Management Market Size by Type (2021-2026)
- 10.2.2 Asia Preterm Birth Prevention and Management Market Size by Type (2027-2032)
- 10.2.3 Asia Preterm Birth Prevention and Management Market Share by Type (2021-2032)
- 10.3 Asia Preterm Birth Prevention and Management Market Size by Application
- 10.3.1 Asia Preterm Birth Prevention and Management Market Size by Application (2021-2026)
- 10.3.2 Asia Preterm Birth Prevention and Management Market Size by Application (2027-2032)
- 10.3.3 Asia Preterm Birth Prevention and Management Market Share by Application (2021-2032)
- 10.4 Asia Preterm Birth Prevention and Management Market Size by Country
- 10.4.1 Asia Preterm Birth Prevention and Management Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Preterm Birth Prevention and Management Market Size by Country (2021-2026)
- 10.4.3 Asia Preterm Birth Prevention and Management Market Size by Country (2027-2032)
- 10.4.4 Asia Preterm Birth Prevention and Management Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Preterm Birth Prevention and Management Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Preterm Birth Prevention and Management Market Size by Type
- 11.2.1 South America, Middle East & Africa Preterm Birth Prevention and Management Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Preterm Birth Prevention and Management Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Preterm Birth Prevention and Management Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Preterm Birth Prevention and Management Market Size by Application
- 11.3.1 South America, Middle East & Africa Preterm Birth Prevention and Management Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Preterm Birth Prevention and Management Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Preterm Birth Prevention and Management Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Preterm Birth Prevention and Management Market Size by Country
- 11.4.1 South America, Middle East & Africa Preterm Birth Prevention and Management Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Preterm Birth Prevention and Management Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Preterm Birth Prevention and Management Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Preterm Birth Prevention and Management Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst